4//SEC Filing
Cannon Louis A 4
Accession 0001387131-18-004275
CIK 0001528557other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:51 PM ET
Size
9.1 KB
Accession
0001387131-18-004275
Insider Transaction Report
Form 4
Cannon Louis A
Director
Transactions
- Purchase
Common Stock
2018-08-24$1.03/sh+15,000$15,461→ 238,909 total - Purchase
Common Stock
2018-08-23$1.02/sh+15,000$15,275→ 223,909 total
Holdings
- 7,557,436(indirect: See Footnote)
Common Stock
Footnotes (6)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9989 to $1.02, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 53,326 shares of common stock related to restricted stock units ("RSUs") granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with Corindus through each such vesting date.
- [F3]143,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- [F4]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.04, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]158,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- [F6]Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
Documents
Issuer
Corindus Vascular Robotics, Inc.
CIK 0001528557
Entity typeother
Related Parties
1- filerCIK 0001700257
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:51 PM ET
- Size
- 9.1 KB